Medifast, Inc. provided earnings guidance for the full year 2023. For the year, the company expects revenue to be in the range of $1,050 million to $1,070 million and full-year 2023 diluted EPS to be in the range of $8.65to $9.55.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.48 USD | -1.67% | -16.06% | -67.86% |
Jun. 05 | DA Davidson Downgrades Medifast to Underperform From Neutral With $17.50 Price Target | MT |
Apr. 30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.86% | 234M | |
+10.73% | 8.07B | |
+8.44% | 7.84B | |
-0.58% | 6.07B | |
-6.40% | 3.71B | |
-13.21% | 3.49B | |
-15.49% | 1.15B | |
+9.98% | 957M | |
-11.57% | 931M | |
-12.76% | 832M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast, Inc. Provides Earnings Guidance for the Full Year 2023